Video Experimental Relacionado
Updated: Aug 1, 2026

09:40
Functional Cloning Using a Xenopus Oocyte Expression System
Published on: January 30, 2016
Hígado de Xenopus: ontogenia de la respuesta al estrógeno
Resumen
El estradiol-17 beta aumenta significativamente la síntesis de proteínas en el hígado del renacuajo Xenopus. Después de la metamorfosis, esta hormona induce específicamente la producción de vitelogenina en el tejido hepático.
Área de la Ciencia:
- Endocrinología Endocrinología.
- Biología del desarrollo Biología del desarrollo.
- Biología Molecular Biología Molecular
Sus antecedentes:
- El estradiol-17 beta es una hormona clave que regula varios procesos fisiológicos.
- El tejido hepático de los renacuajos Xenopus sufre cambios significativos durante la metamorfosis.
- La señalización de estrógenos juega un papel en el desarrollo y el metabolismo de los anfibios.
Objetivo del estudio:
- Para investigar el efecto del estradiol-17 beta en la síntesis de proteínas en el hígado del renacuajo Xenopus.
- Para determinar el tiempo de desarrollo de la producción de proteínas inducida por los estrógenos, específicamente la vitelogenina.
- Para analizar la especificidad de la acción del estradiol-17 beta sobre las proteínas secretadas en el hígado post-metamórfico.
Principales métodos:
- Cultivo primario de tejido hepático de renacuajo Xenopus en diferentes etapas de desarrollo (después de la etapa 50 a la etapa 66).
- Tratamiento con estradiol-17 beta para estimular la síntesis de proteínas.
- Análisis de las proteínas secretadas en el medio de cultivo utilizando técnicas como el radiomarcado y la electroforesis.
Principales resultados:
- El estradiol-17 beta estimula la síntesis de múltiples proteínas secretadas en el hígado del renacuajo Xenopus desde la etapa 50 hasta la metamorfosis.
- La vitelogenina inducida por estrógeno es detectable desde la etapa 54 pero sigue siendo un componente menor hasta que se completa la metamorfosis.
- En el hígado post-metamórfico, el estradiol-17 beta mejora específicamente la síntesis de vitelogenina sin afectar a otras proteínas secretadas.
Conclusiones:
- La influencia del estradiol-17 beta en la síntesis de proteínas hepáticas evoluciona durante la metamorfosis de Xenopus.
- La producción de vitelogenina se convierte en la vía secretora predominante de respuesta al estrógeno en el hígado después de la metamorfosis.
- Esto pone de relieve un papel específico para el estradiol-17 beta en la regulación de la síntesis de precursores de proteína de la yema en el hígado adulto.
Videos de Conceptos Relacionados
Drug Metabolism: Phase I Reactions
A phase I reaction is a biochemical process that introduces a functionally reactive polar group to a substance. This transformation predominantly occurs in the liver, facilitated by the cytochrome P450 system of hemoproteins situated in the lipophilic endoplasmic reticulum of cells. The metabolite generated through this process can have varying polarities. If it is sufficiently polar, it can be easily excreted in the urine due to its water compatibility. However, if the metabolite is nonpolar,...
Phase I Oxidative Reactions: Overview
Phase I biotransformation, or functionalization, is a crucial chemical process that converts drugs and other xenobiotics into more water-soluble forms, facilitating expulsion from the body. It involves oxidative, reductive, and hydrolytic reactions that add or unveil polar functional groups on lipophilic substrates. Key players in phase I reactions are the mixed-function oxidases. Situated in liver cell microsomes, these enzymes predominantly carry out drug metabolism. They require molecular...
Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems
Phase I biotransformation reactions are integral to drug metabolism, predominantly involving oxidative, reductive, and hydrolytic transformations. Chief among these are oxidative reactions, which enhance the hydrophilicity of xenobiotics and introduce polar functional groups to facilitate their elimination from the body.
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
Phase I Reactions: Reductive Reactions
Phase I biotransformation reductive reactions are chemical processes that modify drugs by introducing or revealing polar functional groups via reduction. Enzymes called reductases catalyze these reactions, playing a pivotal role in drug metabolism by transforming lipophilic drugs into more polar, water-soluble metabolites for easy excretion. An essential type of reductive reaction is the carbonyl group reduction, where aldehydes and ketones are reduced to alcohols. An example is the...
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation
Glutathione, a tripeptide made up of glutamate, cysteine, and glycine, is a critical player in the detoxification of drugs and xenobiotics via a process known as glutathione conjugation or mercapturic acid formation. This phase II biotransformation reaction involves the covalent binding of glutathione to a drug or its metabolite, enhancing the compound's water solubility and enabling its excretion.
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Bioactivation and Tissue Toxicity
Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...

